These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 1624542

  • 21. Effect of various oxygenation conditions and fluosol-DA on cytotoxicity and antitumor activity of bleomycin in mice.
    Teicher BA, Holden SA, Cathcart KN, Herman TS.
    J Natl Cancer Inst; 1988 Jun 15; 80(8):599-603. PubMed ID: 2453675
    [Abstract] [Full Text] [Related]

  • 22. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma.
    Teicher BA, Holden SA, al-Achi A, Herman TS.
    Cancer Res; 1990 Jun 01; 50(11):3339-44. PubMed ID: 2334928
    [Abstract] [Full Text] [Related]

  • 23. Combination of perfluorochemical emulsions and carbogen breathing with cancer chemotherapy.
    Teicher BA.
    Artif Cells Blood Substit Immobil Biotechnol; 1994 Jun 01; 22(4):1109-20. PubMed ID: 7849913
    [Abstract] [Full Text] [Related]

  • 24. Differential enhancement of melphalan cytotoxicity in tumor and normal tissue by Fluosol-DA and oxygen breathing.
    Teicher BA, Holden SA, Rose CM.
    Int J Cancer; 1985 Nov 15; 36(5):585-9. PubMed ID: 3932225
    [Abstract] [Full Text] [Related]

  • 25. Optimization of perfluorochemical levels with radiation therapy in mice.
    Teicher BA, Herman TS, Jones SM.
    Cancer Res; 1989 May 15; 49(10):2693-7. PubMed ID: 2713854
    [Abstract] [Full Text] [Related]

  • 26. Combination of etanidazole with cyclophosphamide and platinum complexes.
    Teicher BA, Herman TS, Shulman L, Bubley G, Coleman CN, Frei E.
    Cancer Chemother Pharmacol; 1991 May 15; 28(3):153-8. PubMed ID: 1830248
    [Abstract] [Full Text] [Related]

  • 27. Potentiation of rat brain tumor therapy by fluosol and carbogen.
    Martin DF, Kimler BF, Evans RG, Morantz RA, Vats TS.
    NCI Monogr; 1988 May 15; (6):119-22. PubMed ID: 3127732
    [Abstract] [Full Text] [Related]

  • 28. Effect of Fluosol-DA/O2 on the antitumor activity and pulmonary toxicity of bleomycin.
    Teicher BA, Lazo JS, Merrill WW, Filderman AE, Rose CM.
    Cancer Chemother Pharmacol; 1986 May 15; 18(3):213-8. PubMed ID: 2433068
    [Abstract] [Full Text] [Related]

  • 29. Evidence for macrophage involvement in the enhancement of tumor growth delay with X-ray/Fluosol-DAR/O2 combination therapy.
    Holden SA, Teicher BA, McIntosh NL, Rose CM.
    Anticancer Res; 1987 May 15; 7(3 Pt B):385-90. PubMed ID: 3115174
    [Abstract] [Full Text] [Related]

  • 30. New high O2 carrying perfluorochemical emulsions and/or carbogen: reactions of a human tumor xenograft to irradiation.
    Thomas C, Lartigau E, Malaise EP, Guichard M.
    Int J Radiat Oncol Biol Phys; 1989 May 15; 16(5):1157-60. PubMed ID: 2497094
    [Abstract] [Full Text] [Related]

  • 31. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.
    Rockwell S, Mate TP, Irvin CG, Nierenburg M.
    Int J Radiat Oncol Biol Phys; 1986 Aug 15; 12(8):1315-8. PubMed ID: 3093416
    [Abstract] [Full Text] [Related]

  • 32. Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents.
    Eder JP, Teicher BA, Holden SA, Cathcart KN, Schnipper LE, Frei E.
    Cancer Res; 1989 Feb 01; 49(3):595-8. PubMed ID: 2910481
    [Abstract] [Full Text] [Related]

  • 33. Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.
    Holden SA, Teicher BA, Ara G, Herman TS, Coleman CN.
    J Natl Cancer Inst; 1992 Feb 05; 84(3):187-93. PubMed ID: 1542129
    [Abstract] [Full Text] [Related]

  • 34. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice.
    Fingar VH, Mang TS, Henderson BW.
    Cancer Res; 1988 Jun 15; 48(12):3350-4. PubMed ID: 3130983
    [Abstract] [Full Text] [Related]

  • 35. Modulation of alkylating agents by lonidamine in vivo.
    Teicher BA, Holden SA, Herman TS, Frei E.
    Semin Oncol; 1991 Apr 15; 18(2 Suppl 4):7-10. PubMed ID: 1903216
    [Abstract] [Full Text] [Related]

  • 36. CAI: effects on cytotoxic therapies in vitro and in vivo.
    Teicher BA, Holden SA, Chen YN, Ara G, Korbut TT, Northey D.
    Cancer Chemother Pharmacol; 1994 Apr 15; 34(6):515-21. PubMed ID: 7923563
    [Abstract] [Full Text] [Related]

  • 37. Effect of oxygen on the cytotoxicity and antitumor activity of etoposide.
    Teicher BA, Holden SA, Rose CM.
    J Natl Cancer Inst; 1985 Dec 15; 75(6):1129-33. PubMed ID: 3934448
    [Abstract] [Full Text] [Related]

  • 38. Administration of a perfluorochemical emulsion plus carbogen breathing does not alter radiation pneumonitis.
    Rockwell S, Kelley M, Rosiello RA, Merrill WW, Carter D.
    Proc Soc Exp Biol Med; 1995 Mar 15; 208(3):288-93. PubMed ID: 7878068
    [Abstract] [Full Text] [Related]

  • 39. Use of perfluorochemical emulsions in cancer therapy.
    Teicher BA.
    Biomater Artif Cells Immobilization Biotechnol; 1992 Mar 15; 20(2-4):875-82. PubMed ID: 1391527
    [Abstract] [Full Text] [Related]

  • 40. [Minimal effective dose of perfluorochemical emulsion as a radiosensitizer].
    Hishikawa-Itoh Y, Kato T, Niwa T, Ayakawa Y, Miyata N.
    Nihon Gan Chiryo Gakkai Shi; 1989 Jun 20; 24(6):1243-8. PubMed ID: 2794648
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.